Critical Analysis: Advanced Biomedical Technologies (OTCMKTS:ABMT) versus iRadimed (NASDAQ:IRMD)

iRadimed (NASDAQ:IRMD) and Advanced Biomedical Technologies (OTCMKTS:ABMT) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, analyst recommendations and profitability.

Analyst Ratings

This is a summary of recent ratings for iRadimed and Advanced Biomedical Technologies, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRadimed	0	1	3	1	3.00
Advanced Biomedical Technologies	0	0	0	0	0.00

iRadimed currently has a consensus target price of $120.00, indicating a potential upside of 19.71%. Given iRadimed’s stronger consensus rating and higher probable upside, analysts clearly believe iRadimed is more favorable than Advanced Biomedical Technologies.

Earnings and Valuation

This table compares iRadimed and Advanced Biomedical Technologies”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRadimed	$83.81 million	15.29	$22.48 million	$1.83	54.78
Advanced Biomedical Technologies	N/A	N/A	N/A	N/A	N/A

iRadimed has higher revenue and earnings than Advanced Biomedical Technologies.

Risk and Volatility

iRadimed has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500. Comparatively, Advanced Biomedical Technologies has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500.

Profitability

This table compares iRadimed and Advanced Biomedical Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
iRadimed	27.36%	24.48%	21.25%
Advanced Biomedical Technologies	N/A	N/A	N/A

Insider and Institutional Ownership

92.3% of iRadimed shares are held by institutional investors. 34.6% of iRadimed shares are held by company insiders. Comparatively, 34.1% of Advanced Biomedical Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

iRadimed beats Advanced Biomedical Technologies on 10 of the 11 factors compared between the two stocks.

About iRadimed

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

About Advanced Biomedical Technologies

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.